Fred Alger Management Reduces Stake in Eli Lilly

Institutional investor cuts holdings in pharmaceutical giant by over 39%

Mar. 16, 2026 at 10:18am

Got story updates? Submit your updates here. ›

Fred Alger Management LLC, an institutional investor, has decreased its holdings in shares of Eli Lilly and Company (NYSE:LLY) by 39.2% during the third quarter, according to a recent SEC filing. The firm now owns 95,787 shares of the company's stock, valued at $73,085,000.

Why it matters

This reduction in stake by a major institutional investor could signal a shift in sentiment around Eli Lilly's stock. Institutional investors like Fred Alger Management often have significant influence on the market, so their trading activity is closely watched by analysts and investors.

The details

According to the filing, Fred Alger Management sold 61,822 shares of Eli Lilly during the third quarter, reducing its total holdings to 95,787 shares. The firm cited unspecified reasons for the sell-off, which came amid a broader market rally for Eli Lilly's stock.

  • Fred Alger Management filed the 13F report disclosing the stake reduction on March 16, 2026.
  • The sell-off occurred during the third quarter of the previous fiscal year.

The players

Fred Alger Management LLC

An institutional investment management firm based in New York City.

Eli Lilly and Company

A global pharmaceutical company headquartered in Indianapolis, Indiana, that researches, develops, manufactures, and commercializes a broad range of medicines and therapies.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Fred Alger Management's stake in Eli Lilly could signal a shift in sentiment around the pharmaceutical company's stock, though the specific reasons for the sell-off remain unclear. Investors will be closely watching to see if other major institutional holders follow suit or if Eli Lilly can maintain its recent market momentum.